Guillain Barre syndrome is a rare but serious neurological disease that requires hospitalization in almost all victims and has no known cure. With such a description, employers and people, in general, might be a little cautious about proceeding with the Johnson & Johnson Covid vaccine. The U.S. Food and Drug Administration announced on July 12 that Guillain Barre syndrome is a rare side effect of this vaccine.
It sounds scary, and it might make you think about not encouraging your employees to receive their vaccine, but take a step back. Don’t panic. Here’s what employers need to know.
To keep reading, click here: Guillain Barre May Be a Tragic, Though Rare, Side Effect. Employers Should Promote Covid Vaccines Anyway